• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON GMBH BBL MEDIUM CULTURE 100ML TRYPTICASE SOY BROTH; CULTURE MEDIA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON GMBH BBL MEDIUM CULTURE 100ML TRYPTICASE SOY BROTH; CULTURE MEDIA Back to Search Results
Catalog Number 299107
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problems No Consequences Or Impact To Patient (2199); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/04/2021
Event Type  malfunction  
Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.(b)(4).
 
Event Description
It was reported while using bbl medium culture 100ml trypticase soy broth there was insufficient growth on media.When plated liquid media to tsa, obtained pure growth.There was no report of patient impact.5 cases were affected.
 
Manufacturer Narrative
The following fields were updated due to additional information: d.9.Device available for eval?: yes.D.9.Returned to manufacturer on: 1/11/2021.H.6.Investigation: this memo is to summarize findings on the recent complaint (b)(4) for bbl¿ trypticase¿ soy broth, batch number 0259640 and catalog number 299107.Event description: it was reported that aspergillus brasiliensis atcc 16404 and candida albicans atcc 10231 would not grow.Complaint history review: the complaints trends were reviewed.There were no similar complaints received during that period on this product lot.Therefore, a trend could not be identified.Batch history record (bhr) review: the batch history review did not indicate any discrepancies.All release testing was satisfactory, and no deviations were observed.Sample analysis: pictures were provided showing bottles and a description of the strains used in them.Also, physical sample was provided for further evaluation.A contamination test was performed with the returned samples and no contamination could be detected.An analysis of growth promotion for the media was performed on retention samples.The performance tests on retention samples of the above mentioned batch resulted in excellent growth of the following strains: candida albicans atcc 10231.Aspergillus brasiliensis atcc 16404.After an incubation time of 5 days at 22,5°c ± 2,5°c in aerob atmosphere.Evaluation results: at this stage of our investigation, we have excluded any systemic failure in our production process.No deviation could be found during the qc performance test.The strain did grow as expected.Investigation conclusion: based on the evaluation of the report and based on the qc test results, the complaint was not confirmed.A corrective and preventive action will not be implemented as a trend could not be identified.We would suggest that any prepared plated media be set aside and not use, that does not meet the appearance specification as it is described on the bd certificate of analysis.This is consistent with industry recommendations for inspection of culture media prior to use (e.G.¿good practices for pharmaceutical microbiology laboratories¿, who technical report series, no.961, 2011, annex 2; chapter 1117 ¿microbiology best laboratory practices¿ the united states pharmacopeia; and the difco & bbl manual).
 
Event Description
It was reported while using bbl medium culture 100ml trypticase soy broth there was insufficient growth on media.When plated liquid media to tsa, obtained pure growth.There was no report of patient impact.5 cases were affected.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BBL MEDIUM CULTURE 100ML TRYPTICASE SOY BROTH
Type of Device
CULTURE MEDIA
Manufacturer (Section D)
BECTON DICKINSON GMBH
8-12 tullastrasse
heidelberg 69126
GM  69126
Manufacturer (Section G)
BECTON DICKINSON GMBH
8-12 tullastrasse
heidelberg 69126
GM   69126
Manufacturer Contact
brett wilko
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key11223174
MDR Text Key229592934
Report Number9680577-2021-00003
Device Sequence Number1
Product Code JSE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 11/05/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/25/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date09/24/2021
Device Catalogue Number299107
Device Lot Number0259640
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/11/2021
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/05/2021
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/15/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-